Clostridium difficile: Towards severe outpatient infections?;Clostridium difficile: Vers des infections graves en médecine ambulatoire?

Revue Medicale Suisse

Volumn 6, Issue 266, 2010, Pages 1910-1913

  Copt, Christophe ^a   Christodoulou, Michel ^b   Friolet, Raymond ^b   Berclaz, Raymond ^b   Bettschart, Vincent ^b   Troillet, Nicolas ^a  

^a Institut Central des Hopitaux Valaisans   (Switzerland)

^b Centre Hospitalier du Centre du Valais   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL STRAIN; CASE REPORT; CLOSTRIDIUM DIFFICILE INFECTION; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; EPIDEMIC; EUROPE; HEALTH CARE FACILITY; HUMAN; NORTH AMERICA; OUTPATIENT; VIRULENCE;

ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, MICROBIAL; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; HUMANS; MIDDLE AGED;

EID: 78049234716     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. ** Freeman J, Bauer MP, Baines SD, et al. The changing epidemiology of Clostridium difficile infections. Clin Microbiol Rev 2010;23:529-49.
2. Lamontagne F, Labbé AC, Haeck O, et al. Impact of emergency colectomy on survival of patients with fulminant Clostridium difficile colitis during an epidemic caused by a hypervirulent strain. Ann Surg 2007;245:267-72. (Pubitemid 46148486)
3. * Clements AC, Magalhães RJ, Tatem AJ, et al. Clostridium difficile PCR ribotype 027: Assessing the risks of further worldwide spread. Lancet Infect Dis 2010;10:395-404.
4. Fenner L, Widmer AF, Stranden A, et al. First cluster of clindamycin-resistant Clostridium difficile PCR-ribotype 027 associated disease in Switzerland. Clin Mirobiol Infect 2008;14:514-5. (Pubitemid 351513945)
5. Bauer MP, Notermans DW, van Benthem BHB, et al. First results of the European Clostridium difficile infection survey (ECDIS). Abstract O-85. 19th European Congress on Clinical Microbiology and Infectious Diseases, Helsinki 2009.
6. Labbé AC, Poirier L, MacCannell D, et al. Clostridium difficile infections in a canadian tertiary care hospital before and during a regional epidemic associated with the BI/NADPI/027 strain. Antimicrob Agent Chemother 2008;52:3180-7.
7. Sundram F, Guyot A, Carboo I, et al. Clostridium difficile ribotypes 027 and 106: Clinical outcomes and risk factors. J Hosp Infection 2009;72:111-8.
8. * Hookman P, Barkin JS. Clostridium difficile associated infection, diarrhea and colitis. World J Gastroenterol 2009;15:1554-80.
9. ** Cohen SH, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infections in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010;31:431-55.
10. Goorhuis A, Bakker D, Corver J. et al. Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin Infect Dis 2008;47:1162-70.
11. Rupnik M, Widmer A, Zimmermann O, et al. Clostridium difficile toxinotype V, ribotype 078, in animals and humans. J Clin Microbiol 2008;46:2146.
12. Burns K, Morris-Downes M, Fawley WN, et al. Infection due to C. difficile ribotype 078: First report of cases in the Republic of Ireland. J Hosp Infect 2010;75:287-91.
13. Weese JS. Clostridium difficile in food - innocent bystander or serious threat? Clin Microbiol Infect 2010;16:3-10.
14. Kuiper EJ, van Dissel JT. Spectrum of Clostridium difficile infections outside healthcare facilities. Can Med Assoc J 2008;179:747-8.
15. Wilcox MH, Mooney L, Bendall R, et al. A case-control study of community-associated Clostridium difficile infections. J Antimicrob Chemother 2008;62:388-96. (Pubitemid 351984787)
16. Linsky A, Gupta K, Lawler EV, et al. Proton pump inhibitors and risk for recurrent Clostridium difficile infection. Arch Intern Med 2010;170:772-8.
17. Parkers GC Sanderson JD, Whelan K. The mechanisms and efficacy of probiotics in the prevention of Clostridium difficile-associated diarrhoea. Lancet Infect Dis 2009;9:237-44.
18. Lowy I, Molrine DC, Leav BA, et al. Treatment with monoclonal antibodies against Clostridium difficile toxins. N Engl J Med 2010;362:197-205.